Medical Management vs Mechanical Thrombectomy for Mild Strokes

Abstract

Background: The reviewed literature provides substantial insights into the evolving landscape of stroke management, particularly focusing on the comparison between mechanical thrombectomy (MT) and traditional medical management for mild strokes. Literature Review: The meta-analysis by (Zheng et al., 2017) establishes a foundational understanding of the efficacy of endovascular treatments in the context of comorbidities, suggesting that patients with conditions such as hyperlipidemia and atrial fibrillation may still benefit significantly from MT. This assertion is further supported by the findings of (Kürşad Akpınar et al., 2018), which highlight that even patients with low NIHSS scores can experience favorable outcomes with MT, challenging traditional eligibility criteria. The comparative analysis conducted by (Anchalee Churojana et al., 2018) reinforces this perspective by demonstrating that atrial fibrillation does not adversely impact the outcomes of MT, thereby advocating for a broader application of this intervention. Similarly, (Kaesmacher et al., 2018) provides critical insights into the efficacy of direct MT compared to bridging therapy, suggesting that direct approaches may yield comparable or superior outcomes, particularly for patients ineligible for thrombolysis. Conclusion: Finally, the synthesis of advancements in MT by (Raha et al., 2023) encapsulates the ongoing evolution in treatment protocols and eligibility criteria, highlighting the expanding scope of patients who can benefit from this intervention. Together, these findings advocate for a paradigm shift in the treatment of acute ischemic strokes, particularly for patients with mild symptoms, emphasizing the need for a more aggressive approach through mechanical thrombectomy to significantly improve patient outcomes.